Anhui Sun Angel Pharmaceutical Co., Ltd & Huainan Lianke Biological Co., Ltd, are located in the Huainan Economic and Technological Development Zone , both are wholly-owned subsidiary of Anhui Lianchuang Biological Medicine Co., Ltd. Anhui Sun Angel Pharmaceutical Co., Ltd covers an area of more than 50,000 square meters, with a total investment of 350 million yuan, building 10 CGMP-compliant workshops as well as quality inspection, storage, environmental protection and other supporting facilities. It mainly produces diabetes control series APIs: representative products include Repaglinide, Miglitol, Dapagliflozin, Canagliflozin, Empagliflozin, Sitagliptin, Ligliptin, Minobalin, Epalrestat, Smeaglutide, etc. Huainan Lianke Biological Co., Ltd covers an area of more than 30,000 square meters and has built a comprehensive multi-functional workshops and related supporting facilities integrating the development of characteristic APIs, customized production of innovative drugs and industrialization of bioenzyme catalytic technology.

The company has built multiple technology platforms to better serve its customers: --We have established the library of hundreds of oxidoreductase and transaminase and developed dozens of commercialized green synthesis processes to support cost reduction, efficiency and safe production of products; --Heterocyclic compounds are difficult to synthesize and have high technical barriers, we have established a comprehensive library of spirocyclic molecules to meet the needs of our customers at the R&D and commercialization stages; --Lipid chain series play an important role in drug delivery and structural modification, and we have developed a lipid series of compounds based on long-acting insulin and GLP-1 side chains; --Provide intermediates for each step of API.